Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) KSC

Currency In KRW

AD

Valuation

Market Cap22.25B
Enterprise Value82.52B
P/E Ratio-3.57
PEG Ratio-0.04
Price/Sales Ratio0.31
Price/Book Ratio1.13
Enterprise/Revenue0.32
Enterprise/EBITDA-4.12

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.14
Operating Margin-0.1
AD

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.19

Income Statement

Revenue87.17B
Revenue/Share871.59
Gross Profit36.36B
EBITDA-20.73B
Net Income-25.74B
Diluted EPS-1,125.56

Balance Sheet

Total Cash37.47B
Total Cash/Share397.94
Total Debt38.61B
Total Debt/Equity0.44
Current Ratio1.24
Book Value Per Share929.13

Price History

52-Week Change7.5
52-Week High2,525
52-Week Low973
Moving Average 50 Days1,268.3
Moving Average 200 Days1,120.92

Statistics

Average Volume127,366
Shares Outstanding24.41M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor5:1
Last Split DateDecember 22, 2008
AD